William Blair has acquired Armentum Partners, a debt and alternative capital solutions advisory firm, in a move to expand its investment banking platform. This acquisition marks William Blair’s second investment banking deal of the year and signals a continued investment in key growth sectors like healthcare, technology, and the venture capital ecosystem.

The transaction enhances William Blair’s capital markets and debt advisory services by incorporating enterprise value and asset-based lending, as well as royalty monetization capabilities. Armentum Partners, founded on expertise in healthcare and technology, specializes in advising high-growth potential companies on customized capital solutions. The firm leverages its relationships within venture capital and public companies, along with access to growth-focused lenders, to deliver tailored financing and execution.

Armentum Partners also assists academic institutions and life sciences companies in monetizing royalties, enabling them to capitalize on their intellectual property. The firm has professionals located in Boston, Chicago, Menlo Park, New York, Philadelphia, and San Francisco, serving clients in both the U.S. and Europe. As a result of the acquisition, William Blair will establish an office in Menlo Park, strengthening its presence in Silicon Valley.

All Armentum Partners professionals are expected to join William Blair, maintaining their established relationships and specialized knowledge. Matt Zimmer, global head of investment banking at William Blair, stated that the firm is investing in capabilities and team members who can deliver differentiated outcomes for clients across the venture capital, public company, and collegiate communities. He noted that the Armentum Partners team has extensive experience earning the trust of clients, investors, and lenders.

Steve Maletzky, head of capital markets at William Blair, described the acquisition as a synergistic extension of their capital markets strategy. He highlighted enterprise value lending as a specialized area that finances companies based on asset value, often before traditional cash flows are established. Maletzky added that Armentum Partners has built a leading franchise advising prominent public companies, universities, and venture-backed businesses in this space.

Hutch Corbett of Armentum Partners commented that their firm was built with a client-focused approach, providing access to deep market relationships and expertise in delivering bespoke solutions. He believes joining William Blair will unlock opportunities for their clients by offering increased scale, reach, and sector depth. Corbett also noted that clients will benefit from continuity in relationships and execution, with access to a broader set of services including public and private equity capital raising, M&A advisory, and equity research.

Investment Banking Platform Expansion

The acquisition occurs amidst significant growth in the private credit and direct lending markets. Venture-backed and public companies are increasingly seeking flexible, non-dilutive capital to fund expansion in areas such as healthcare innovation, artificial intelligence, software, consumer goods, media, fintech, and industrial technology. This includes financing for acquisitions and growth initiatives.

Black and white photo of the New York Stock Exchange facade with USA flag
Black and white photo of the New York Stock Exchange facade with USA flag. Illustrative stock photo via Pexels.

Demand is particularly strong among later-stage technology companies and biopharmaceutical firms that require funding for clinical trials and commercialization. William Blair has been actively investing in and deepening its expertise in these segments. The firm’s ongoing expansion in life sciences includes the recent addition of Michael Allwin as head of Biopharma investment banking, Emanuela Branchetti as managing director of scientific affairs, and Alethia Young in equity research.

Armentum Partners will continue to operate under its existing name for a period following the transaction’s closure. Clearsight Advisors, Inc. served as the financial advisor to Armentum in connection with the deal. Armentum Partners, founded in Silicon Valley, has raised over $22 billion across more than 390 transactions since its inception. William Blair’s investment banking group has advised on over $880 billion in completed transaction volume from July 2021 through June 2026.

William Blair, an employee-owned firm, provides advisory services, strategies, and solutions through its investment banking, investment management, and private wealth management divisions. The firm operates in more than 30 offices worldwide, including strategic alliances with Allier Capital, BDA Partners, and Poalim Equity Ltd.

Frequently asked questions

  • What is Armentum Partners?

    Armentum Partners is an independent financial advisory firm that raises debt and non-dilutive capital, primarily for technology and healthcare companies. They also have an active royalty monetization practice.

  • What capabilities does William Blair gain from this acquisition?

    William Blair gains enterprise value and asset-based lending, as well as royalty monetization capabilities. This expands their capital markets and debt advisory solutions.

  • In which sectors does Armentum Partners specialize?

    Armentum Partners specializes in advising companies with high-growth potential, particularly in the healthcare and technology sectors. They also serve academic institutions and life sciences companies.

  • What is the impact of this acquisition on William Blair's presence in Silicon Valley?

    The acquisition will result in William Blair opening an office in Menlo Park, establishing a presence in the heart of Silicon Valley.

  • How does this acquisition align with market trends?

    The transaction aligns with rapid expansion in private credit and direct lending markets, as companies increasingly seek flexible, non-dilutive capital for growth.